APPLIED BIOLOGICAL MATERIALS INC. (ABM)

Company Snapshot

Founded: 2004
Entity Type: Private
Region: Canada
Headquarter: British Columbia, Canada
Key Geographics: Canada, U.S., China
Corporate Address: 1-3671 Viking Way Richmond, British Columbia V6V 2J5 Canada Tel. +1-604-247-2416 www.abmgood.com

Company Overview

Applied Biological Materials Inc. (ABM) develops and markets products and services for researchers. Its product lines cover many cutting-edge technologies, such as CRISPR genome editing, RT-PCR, PCR, qPCR, cell immortalization, antibodies, and adenoviral and lentiviral expression systems. ABM also offers custom services to create novel solutions to experimental challenges, including iPSC generation.

The company’s iPSC-related products include iPSC reprogramming factors in protein, lentivirus, adenovirus, minicircle, and plasmid formats; iPSC characterization kits; iPSC small molecules; growth factors; stemporters; iPSC antibodies; and iPSC feeder cells.

Applied Biological Materials Inc. distributes to more than 60 nations worldwide. It can conveniently send its merchandise right to the doorstep thanks to a robust global network. It collaborates with reliable distributors to deliver the highest level of goods, support and clientele.

APPLIED BIOLOGICAL MATERIALS INC. (ABM) In Reports

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says global market for induced pluripotent stem cells is expected to grow from $3.4 billion in 2023 and forecast to reach $5.2 billion by the end of 2028 at a CAGR of 9.1%.

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says induced pluripotent stem cells should grow from $2.8 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate of 9.3%.

Viral Vector and Plasmid DNA: Technologies and Global Markets

The global viral vector and plasmid DNA technologies market should grow from $500 million in 2019 to over $1.1 billion by 2024 with a compound annual growth rate (CAGR) of 18.0% during the period, 2019-2024.

Company's Business Segments

  • Life Sciences and Drug Development : This segment includes PCR Enzymes, Molecular Biology Enzymes & Kits, Antibodies, Transfection Reagents, Genetic Materials, Expression-Ready cDNA Libraries, Cell & Antibody Services, DNA & Cloning Services, Virus Packaging Services and many others.

Applications/End User Industries

  • Healthcare
  • Biotechnology
  • Pharmaceuticals
  • Technology Transfer
  • Assay Development
  • Cell Line Generation
  • Recombinant Virus Packaging
  • Antibody Drug Development
  • R&D Organizations
  • OEM & Distribution
AI: Your Say